NAFLD is a risk factor for the development of diabetic nephropathy in patients with T2DM

Authors

DOI:

https://doi.org/10.3126/ajms.v14i5.51924

Keywords:

Non-alcoholic fatty liver disease (NAFLD); Diabetic nephropathy; Type 2 diabetes mellitus

Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) and diabetes are two common health problems of global concern. Diabetic nephropathy (DN) is also a microvascular complication of diabetes. However, there is little knowledge about the relationship between NAFLD and DN.

Aims and Objectives: The aim of this study was to know the association between NAFLD and DN in type 2 diabetes mellitus (T2DM) patients.

Materials and Methods: A cross-sectional study was conducted on 136 patients of T2DM admitted to Sanjay Gandhi memorial Hospital, Rewa. Using abdominal ultrasonography, patients were grouped as patients, with NAFLD and patients without NAFLD. Then, patients were screened for DN (microalbuminuria) using the dipstick method. Liver and kidney function tests and complete blood count were performed along with FBS, PPBS, and HbA1c. Data were analyzed by appropriate statistical tests by Wizard 2® (Version 2.0.12 (259)) software. P<0.05 was considered significant.

Results: In this study, 61 (44.85%) patients were found to have NAFLD, and 30 (49.81%) also had DN. Out of 75 (55.14%) non-NAFLD patients, 21 (28%) had DN. The data were statistically significant (OR: 2.4885, 95%, P=0.0120). The mean estimated glomerular filtration rate (eGFR) (mL/min/1.73 m2) among subjects with FIB4 score ≥2.67 was 77.33±9.54 and was less as compared to the mean eGFR among subjects with FIB4 score <2.67 (104.12±5.23) (student t-test, t (134)=2.247, P=0.026).

Conclusion: NAFLD might be a risk factor for the development of DN in T2DM patients.

Downloads

Download data is not yet available.
Abstract
28
PDF
64

Downloads

Published

2023-05-01

How to Cite

Usmani MH, Karan Saran Kapur, & Ranjeet Singh Sisodiya. (2023). NAFLD is a risk factor for the development of diabetic nephropathy in patients with T2DM. Asian Journal of Medical Sciences, 14(5), 66–70. https://doi.org/10.3126/ajms.v14i5.51924

Issue

Vol. 14 No. 5 (2023)

Section

Original Articles

License

Copyright (c) 2023 Asian Journal of Medical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).